BioTech Medics, Inc. to Acquire Waterview Office Complex-Dallas
13 Febrero 2006 - 11:05AM
PR Newswire (US)
DALLAS, Feb. 13 /PRNewswire-FirstCall/ -- BioTech Medics, Inc.,
(OTC Pink Sheets: BTMD) announces that it has entered into a Letter
of Intent with the Owners to acquire nearly 6 acres and over 90,640
sq. ft. of office complex known as The Waterview Complex at 9535
Forest, Dallas, Texas. Keith Houser, CEO has stated: "We continue
our pledge to our shareholders to add significant assets to the
Company through mergers and acquisitions. This property when fully
leased appraises at almost $12 million. This will give BTMD a
permanent location for our international headquarters and our Pain
Management & Wellness Center in North Dallas. Due to our prior
merger with FHJ and the 5 SHBAN solution patent acquisition and the
pending merger acquisition with Harwood Enterprises Worldwide
Nutraceutical Company, BTMD ultimately plans on occupying up to
20,000 square feet of the Waterview building. Existing tenants and
future ancillary tenants will be completing the occupancy over the
next year." BioTech has also entered into an agreement with a
private real estate investment group who will be providing some
equity and bank financing for the acquisition. Closing is expected
on or about April 10, 2006. BioTech Medics is a distributor for the
NeuroLase Therapeutic Medical Laser. It owns a Pain Management and
Wellness Center in Dallas and plans on opening more this year
nationwide. Check out BTMD's web site at:
http://www.biotechmedics.com/ . Contact: Keith Houser Phone
972-274-5533 Safe Harbor for Forward-Looking Statements. This press
contains forward-looking statements within the meaning of The
Private Securities Litigation Reform Act of 1995 (the "Act"). In
Particular, when used in the preceding discussion, the words
"plan," "confident that," "believe," "scheduled," "expect," or
"intend to," and similar conditional expressions are intended to
identify forward-looking statements within the meaning of the Act
and are subject to the safe harbor created by the Act. Such
statements are subject to certain risks and uncertainties and
actual results could differ materially from those expressed in any
of the forward-looking statements. Such risks and uncertainties
include, but are not limited to, the ability of the company to
complete the planned bridge financing, market conditions, the
general acceptance of the Company's products and technologies,
competitive actors, timing, and other risks. DATASOURCE: BioTech
Medics, Inc. CONTACT: Keith Houser of BioTech Medics, Inc.,
+1-972-274-5533 Web site: http://www.biotechmedics.com/
Copyright